Brainstorm Cell Therapeutics In dividends

Sorry, we have no dividends for Brainstorm Cell Therapeutics In (BCLI) at the moment. :(

BCLI

Price: $0.54

52 week price:
0.13
3.37

Earnings Per Share: -0.42 USD

P/E Ratio: -0.92

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 566900

Ebitda: -2.4 million

Market Capitalization: 28.3 million

Links: